Developing a new MRI method for breast cancer screening without contrast agents
Abbreviated Non-Contrast-Enhanced MRI for Breast Cancer Screening
This study is working on a new way to use MRI for breast cancer screening that’s quicker and doesn’t need any special dyes, making it easier and more comfortable for women at high risk, especially those with dense breast tissue who might be overlooked by regular mammograms.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11019719 on NIH RePORTER |
What this research studies
This research focuses on creating a fast and accurate MRI screening method for breast cancer that does not require contrast agents, making it more accessible and comfortable for women at high risk. The approach involves advanced imaging techniques that enhance the detection of breast lesions, particularly in women with dense breast tissue who are often missed by traditional mammography. By utilizing innovative 3D and 2D diffusion MRI methods, the study aims to improve the sensitivity of breast cancer detection while minimizing discomfort and costs associated with current screening methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are women at high risk for breast cancer, including those with dense breast tissue or a family history of the disease.
Not a fit: Patients who do not have a high risk for breast cancer or those who have already been diagnosed with breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and comfortable breast cancer screening option for women at high risk, potentially saving lives through earlier detection.
How similar studies have performed: Previous research has shown that MRI can significantly improve breast cancer detection rates, indicating that this approach has the potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Hargreaves, Brian Andrew — Stanford University
- Study coordinator: Hargreaves, Brian Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.